96924 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Acute pancreatitis-associated protein
COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#2Use of peptide compounds in treating acute pancreatitis
#3COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#4Use of peptide compounds in treating acute pancreatitis
#5Compositions and methods of using islet neogenesis peptides and analogs thereof
#6COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#7Compositions and methods of using islet neogenesis peptides and analogs thereof
#8MODIFIED INGAP PEPTIDES FOR TREATING DIABETES
#9Compositions and methods of using islet neogenesis peptides and analogs thereof
#10Peptides, derivatives and analogs thereof, and methods of using same
#11ASSAY FOR THE DETECTION OF FACTORS THAT MODULATE THE EXPRESSION OF INGAP
#12Peptides, derivatives and analogs thereof, and methods of using same
#13Compositions and methods of using proislet peptides and analogs thereof
#14COMPOSITIONS AND METHODS OF USING THE HUMAN PROISLET PEPTIDE RECEPTOR
#15Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis
#16Truncated PAP2 and methods of making and using same
#17Peptides, derivatives and analogs thereof, and methods of using same
#18ASSAY FOR THE DETECTION OF FACTORS THAT MODULATE THE EXPRESSION OF INAGP
#19Peptides, derivatives and analogs thereof, and methods of using same
#20Composition and method for treating diabetes
#21Peptides, derivatives and analogs thereof, and methods of using same
#22INGAP displacement assays